ARTICLE | Company News
Cephalon, MDS Proteomics deal
January 7, 2003 8:00 AM UTC
CEPH will use technology from MDS Proteomics, a subsidiary of MDS (TSE:MDS; MDZ), to aid in expanding potential indications for CEPH compounds, enhancing its chemical library and identifying CNS targe...